TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma.

Adi Diab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.